The interleukin 22 pathway interacts with mutant KRAS to promote poor prognosis in colon cancer. by McCuaig, S, Barras, D, Mann, E, Friedrich, M, Bullers, SJ, Janney, A, Garner, LC, Domingo, E, Koelzer, VH, Delorenzi, M, Tejpar, S, Maughan, TS, West, NR, Powrie, F

Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes by Thompson, KN, Bonham, KS, Ilott, NE, Colmenero, P, Bullers, SJ, Brough, I, Pearson, C, Moussa, C, Kumar, V, Lam, LH, Jackson, MA, Kiriakidis, S, Taylor, PC, Marsden, B, Bowness, P, Powrie, F

IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies by Friedrich, M, Pohin, M, Jackson, MA, Korsunsky, I, Bullers, SJ, Rue-Albrecht, K, Christoforidou, Z, Sathananthan, D, Thomas, T, Ravindran, R, Tandon, R, Peres, RS, Sharpe, H, Wei, K, Watts, GFM, Mann, EH, Geremia, A, Attar, M, Barone, F, Brenner, M, Buckley, CD, Coles, M, Frei, AP, Lassen, KG, Powrie, FM, McCuaig, S, Thomas, L, Collantes, E, Uhlig, HH, Sansom, SN, Easton, A, Raychaudhuri, S, Travis, SP, Powrie, FM